NeuroBo Pharmaceuticals, Inc. (NRBO)

NASDAQ: NRBO · IEX Real-Time Price · USD

3.060

-0.040 (-1.29%)

At close: Apr 25, 2024, 12:00 AM

3.150

+0.090 (2.94%)

Pre-market: Apr 26, 2024, 9:28 AM EDT

NeuroBo Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Net Income	-12.47	-13.97	-15.28	-29.68	-21.31	-15.53	-33.42	-14.95	-13.04	-0.32
Depreciation & Amortization	0.01	0.03	0.07	0.07	0.02	0	0	0	0	0
Share-Based Compensation	0.22	0.85	0.66	0.7	0.12	0	5.27	1.72	0.28	0.05
Other Operating Activities	1.44	1.37	-0.58	18.15	14.14	1.08	1.24	1.83	3.31	0.07
Operating Cash Flow	-10.8	-11.71	-15.13	-10.76	-7.04	-14.45	-26.9	-11.04	-5.43	-0.2
Capital Expenditures	-0.05	0.01	-0	-0	-0.21	-0	0	0	0	0
Acquisitions	0	0	-0.58	0.07	-5.84	0	0	0	0	0
Investing Cash Flow	-0.05	0.01	-0.59	0.07	-6.06	-0	0	0	0	0
Share Issuance / Repurchase	0	32.25	24.12	7.55	0	0	12.58	30.28	0	0
Debt Issued / Paid	0	0	0	0	0	0.5	9.91	5.14	7.42	0.51
Other Financing Activities	-0.08	-3.57	-2.09	-0.7	24.17	16.75	-1.15	-3.96	1.32	-
Financing Cash Flow	-0.08	28.68	22.03	6.86	24.17	17.25	21.34	31.46	8.74	0.51
Exchange Rate Effect	0	0	-0.01	0	0.01	0	0	0	0	0
Net Cash Flow	-10.93	16.98	6.31	-3.84	11.07	2.79	-5.56	20.41	3.3	0.31
Free Cash Flow	-10.85	-11.7	-15.14	-10.77	-7.25	-14.45	-26.9	-11.04	-5.43	-0.2
Free Cash Flow Per Share	-2.14	-36.38	-156.98	-159.37	-333.24	-816.05	-15597.64	-11406.45	-11339.35	-768.95

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).